SSWM
DXCM icon

Sheets Smith Wealth Management’s DexCom DXCM Stock Holding History

Sheets Smith Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,251
Closed -$451K – 383
2024
Q1 		$451K Buy
+3,251
New +$409K 0.05% 259
2023
Q3 		– Sell
-3,431
Closed -$441K – 489
2023
Q2 		$441K Buy
+3,431
New +$415K 0.06% 220
2020
Q4 		– Sell
-4,024
Closed -$415K – 337
2020
Q3 		$415K Buy
+4,024
New +$420K 0.07% 208
2020
Q2 		– Sell
-8,796
Closed -$592K – 268
2020
Q1 		$592K Buy
+8,796
New +$547K 0.12% 146

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sheets Smith Wealth Management's DXCM Position: Q2 2024 in Review

Sheets Smith Wealth Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 3,251 shares — an estimated $451K sold.

Sheets Smith Wealth Management first reported a position in DXCM in Q1 2020 and held it in 4 quarters. The position peaked at $592K in Q1 2020. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Sheets Smith Wealth Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 3,251 DexCom shares in Q2 2024, an estimated $451K.
  • Sheets Smith Wealth Management first reported a position in DexCom in Q1 2020 and held it in 4 quarters.
  • Sheets Smith Wealth Management's DexCom position peaked at $592K in Q1 2020.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2024, filed 30 Jul 2024.